RLAY- Relay Therapeutics, Inc.

Name: Relay Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Relay Therapeutics, Inc. (RLAY) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. RLAY is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Patel Sanjiv	1.45M	$20.43M	-
Pres	Bergstrom Donald A	420.0K	$5.92M	-
Other	Adams Brian	371.5K	$5.23M	-
Other	Rahmer Peter	276.6K	$3.90M	-
CFO	Catinazzo Thomas	215.7K	$3.04M	-

Activity

Buys and sells only

Transactions

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 27, 2023	Rahmer Peter63	See Remarks	Sell	297	$15.36	$4,561.92	-0.2%	-21.8%	-51.1%
Mar 27, 2023	Catinazzo Thomas71	Chief Financial Officer	Sell	347	$15.36	$5,329.92	-0.2%	-21.8%	-51.1%
Mar 27, 2023	Bergstrom Donald A75	President, R&D	Sell	763	$15.36	$11,719.68	-0.3%	-21.8%	-51.1%
Mar 27, 2023	Adams Brian72	Chief Legal Officer	Sell	347	$15.36	$5,329.92	-0.3%	-21.8%	-51.1%
Feb 9, 2023	Patel Sanjiv74	President And CEO	Sale+OE	42,000	$20.99	$881,720.00	-100%	-46.6%	-54.7%
Jan 30, 2023	Rahmer Peter63	See Remarks	Sell	740	$21.56	$15,954.40	-0.5%	-45.4%	-54.5%
Jan 30, 2023	Catinazzo Thomas71	Chief Financial Officer	Sell	864	$21.56	$18,627.84	-0.6%	-45.4%	-54.5%
Jan 30, 2023	Bergstrom Donald A75	President, R&D	Sell	1,429	$21.56	$30,809.24	-0.6%	-45.4%	-54.5%
Jan 30, 2023	Adams Brian72	Chief Legal Officer	Sell	864	$21.56	$18,627.84	-0.6%	-45.4%	-54.5%
Jan 19, 2023	Patel Sanjiv74	President And CEO	Sale+OE	84,000	$20.37	$1,711,360.00	-9.9%	-38.9%	-49.6%

← PrevPage 10Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC